Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL632492

Review assay metadata, readout intent, target linkage, and publication context from the same page.

ADMET
Inhibition of the increase of serum calcium levels in a dose-dependent fashion after subcutaneous infusion for 6 hr to TPTX rats at doses 0.20, 0.67, and 2 mg/kg/h
1
Total Activities
1
Compounds Tested
1
Activity Types
1
Assay Parameters

Assay Information

Assay Type ADMET
Organism Rattus norvegicus
Tissue Serum
Confidence 1 — Organism
Curated By Intermediate

Target

Rattus norvegicus (CHEMBL376)
Type ORGANISM
Organism Rattus norvegicus

Publication

Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist.
Duggan ME, Duong LT, Fisher JE, Hamill TG, Hoffman WF, Huff JR, Ihle NC, Leu CT, Nagy RM, Perkins JJ, Rodan SB, Wesolowski G, Whitman DB, Zartman AE, Rodan GA, Hartman GD.
J Med Chem (2000) 43 : 3736 -3745
PubMed 11020288 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 1 6.70 6.70

Assay Parameters

Parameter Type Value Units Text
ROUTE ROUTE - Subcutaneous

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL123262 1 6.70

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL123262 IC50 = 200.0 nM 6.70